aktien Suche

NeuroPace Inc Aktie

[NPCE | ISIN US6412881053]
7,44 $ 0,95%
Echtzeit-Preisindikation
Bid: 7,44 $ Ask: 7,44 $
Unternehmensprofil

Was macht NeuroPace Inc?

Unternehmensprofil

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Chart der NeuroPace Inc Aktie

Aktuelle Nachrichten zu NeuroPace Inc

Unsere neuesten Artikel zu NeuroPace Inc